Overview

Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera

Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
Hepatitis C virus (HCV) infection is associated with significant morbidity and mortality owing to progression of a high percentage (85%) of HCV infected patients to chronic hepatitis, which might lead to the development of liver cirrhosis or hepato cellular carcinoma.. Egypt has possibly the highest HCV prevalence in the world, 10-20% of the general population .
Phase:
Early Phase 1
Details
Lead Sponsor:
Assiut University
Treatments:
Mitogens
Sofosbuvir